1. Industry
Send to a Friend via Email

Your suggestion is on its way!

An email with a link to:

http://pharma.about.com/od/A/g/Abbreviated-New-Drug-Application.htm

was emailed to:

Thanks for sharing About.com with others!

You can opt-out at any time. Please refer to our privacy policy for contact information.

Abbreviated New Drug Application

By

Definition:

An Abbreviated New Drug Application (ANDA) is submitted to the FDA when seeking review and approval for a generic drug product. The application is submitted to the FDA's Center for Drug Evaluation and Research, Office of Generic Drugs. If approved, the generic drug may be manufactured and sold in the U.S. market.

Generic drug applications are not typically required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness. An applicant submitting an ANDA must scientifically demonstrate that its product is bioequivalent to the previously approved innovator or brand name drug.

  1. About.com
  2. Industry
  3. Pharma
  4. Glossary
  5. A
  6. Abbreviated New Drug Application (ANDA)

©2014 About.com. All rights reserved.